Pesquisar
CorMedix Inc
CRMDAdicionar à lista de desejos
8.750USD
+0.280+3.31%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
686.45MValor de mercado
3.60P/L TTM
Mais detalhes de CorMedix Inc Empresa
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
Informações de CorMedix Inc
Código da empresaCRMD
Nome da EmpresaCorMedix Inc
Data de listagemMar 25, 2010
CEOTodisco (Joseph)
Número de funcionários64
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 25
Endereço300 Connell Drive
CidadeBERKELEY HEIGHTS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07922
Telefone19085179500
Sitehttps://cormedix.com/
Código da empresaCRMD
Data de listagemMar 25, 2010
CEOTodisco (Joseph)
Executivos da empresa CorMedix Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
Mr. Myron M. Kaplan, J.D.
Mr. Myron M. Kaplan, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Matthew T. (Matt) David, M.D.
Dr. Matthew T. (Matt) David, M.D.
Chief Business Officer
Chief Business Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
Perguntas frequentes
Quem são os cinco principais acionistas de CorMedix Inc?
Os cinco principais acionistas de CorMedix Inc são: Mr. Joseph (Joe) Todisco
Quantas instituições possuem ações da CorMedix Inc (CRMD)?
Em 2026Q1, 390 instituições possuíam ações da CorMedix Inc, com valor de mercado aproximado de 43.28M, representando 55.17% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -18630389.00.